Загрузка...
Neprilysin inhibition in chronic kidney disease
Despite current practice, patients with chronic kidney disease (CKD) are at increased risk of progression to end-stage renal disease and cardiovascular events. Neprilysin inhibition (NEPi) is a new therapeutic strategy with potential to improve outcomes for patients with CKD. NEPi enhances the activ...
Сохранить в:
| Опубликовано в: : | Nephrol Dial Transplant |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425478/ https://ncbi.nlm.nih.gov/pubmed/25140014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu269 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|